Can Nirma make the jump from suds to pills?
Finshots Daily
00:00
Introduction
Exploring Nirma's entry into the pharmaceutical industry through its investment in Glenmark Life Sciences and examining the challenges and potential success of this unexpected move.
Play episode from 00:00
Transcript
